News und Analysen
EnWave Signs Technology Evaluation and License Option Agreement with American Industrial Hemp Producer
Vancouver, B.C., October 14, 2020 - EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company” - https://www.commodity-tv.com/ondemand/companies/profil/enwave-corp/) announced today
EnWave unterzeichnet Technologiebewertungsabkommen inklusive Lizenzoptionen mit amerikanischem Industriehanfproduzenten
Vancouver, B.C., 14. Oktober 2020 - Die EnWave Corporation (TSX-V:ENW | FSE:E4U) ("EnWave", oder das "Unternehmen" - https://www.commodity-tv.com/ondemand/companies/profil/enwave-corp/) gab
Waters ACQUITY PREMIER Columns Set a New Standard of Performance for Chromatographic Analyses
Waters Corporation (NYSE:WAT) today introduced ACQUITY™ PREMIER Columns, a new family of premium sub-2-micron columns featuring MaxPeak™ High Performance Surface (HPS) technology. The columns are
Agilent Early Career Professor Award Presented to Carl DeSelm
Agilent Technologies Inc. (NYSE: A) today announced that Carl DeSelm, M.D., Ph.D., has received the 2020 Agilent Early Career Professor Award. Dr. DeSelm is an assistant professor of Radiation
Exact Sciences Selects Veeva Vault Clinical Suite to Help Accelerate Innovation
Veeva Systems (NYSE: VEEV) today announced that Exact Sciences, a leading provider of cancer screening and diagnostic tests, selected Veeva Vault Clinical Suite to design and run its clinical
Aurinia Pharmaceuticals Announces Launch of Lupus Nephritis Disease-State Awareness Initiative for Healthcare Professionals, TimeIsNephrons.com
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH / TSX:AUP) (“Aurinia” or the “Company”) today announced Time Is Nephrons, the first-ever lupus nephritis (LN) disease-state awareness campaign for
NanoString Technologies Announces Closing of Public Offering of $230.0 Million of Common Stock Including Exercise in Full of Option to Purchase Additional Shares
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the closing of its previously announced underwritten
Premier, Inc. to Report Fiscal 2021 First-Quarter Results and Host Conference Call on November 2, 2020
Premier, Inc. (NASDAQ: PINC) today announced that it will release financial results for its fiscal 2021 first quarter on Monday, November 2, 2020, at approximately 4:15 p.m. ET. The company will
Humana Welcomes Additional Retail Pharmacies to Preferred Medicare Part D Network
Humana Inc. (NYSE: HUM), a leading health and well-being company, has announced that Kroger Health and its family of pharmacies, Costco, Publix and HEB have joined its preferred stand-alone
QIAGEN veröffentlicht starke vorläufige Zahlen für das dritte Quartal 2020
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) gibt vorläufige Zahlen für Umsatz und bereinigtem Gewinn pro Aktie für das dritte Quartal 2020 bekannt.
Der Nettoumsatz stieg sowohl zu
QIAGEN reports strong preliminary results for third quarter of 2020
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today preliminary sales and adjusted earnings per share (EPS) results for the third quarter of 2020.
Net sales grew 26% at actual
Simulations Plus Announces Quarterly Cash Dividend of $0.06 per Share
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today announced that
Simulations Plus Teams Up with the University of Health Sciences and Pharmacy in St. Louis to Secure New Grant Award from the U.S. FDA
Simulations Plus, Inc. (Nasdaq: SLP), the leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today announced
Charles River Laboratories Schedules Third-Quarter 2020 Earnings Release and Conference Call
Charles River Laboratories International, Inc. (NYSE: CRL) will release third-quarter 2020 financial results on Thursday, October 29th, before the market opens. A conference call has been scheduled
Dexcom Appoints Kyle Malady to Board of Directors
DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring, today announced the appointment of Kyle Malady to its Board of Directors, effective immediately.
Mr
LivaNova präsentiert auf der Jahrestagung der European Association for Cardio-Thoracic Surgery neue Daten zur Demonstration der Vorteile der nahtlosen Percevalklappe
LivaNova PLC (NASDAQ:LIVN), ein marktführendes Medizintechnik- und Innovationsunternehmen, gab heute neue Daten aus der klinischen Studie über Perceval®, dem nahtlosen Implantat im Vergleich zum
Evotec: Jetzt ist auch Abu Dhabi an Bord
Wie das Hamburger Biotechnologieunternehmen Evotec (WKN: 566480) heute früh vermeldete, investieren die Mubadala Investment Company sowie die Novo Holdings 250 Millionen Euro im Rahmen einer
Formycon: Sensationelle News!
Wie der Biosimilar-Spezialist Formycon (WKN: A1EWVY) heute früh vermeldete, erhält man Fördermittel in Höhe von 290.000 Euro für das Projekt "Charakterisierung von ACE2-IgG-Konstrukten", einem
Sirona Biochem Signs Agreement with Global Pharmaceutical Company for Clinical Trial of its Novel Skin Care Compound TFC-1067
Vancouver, Canada - October 13, 2020 - Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (US-OTC: SRBCF) (“Sirona”) is pleased to announce that it has signed an agreement with a top 10 global
Sirona Biochem unterzeichnet Vertrag mit weltweit agierendem Pharmaunternehmen für klinische Studie zu seinem neuartigen Hautpflegewirkstoff TFC-1067
Vancouver, Kanada - 13. Oktober 2020 - Sirona Biochem Corp. (TSX-V: SBM) (FWB: ZSB) (US-OTC: SRBCF) („Sirona“) freut sich bekannt zu geben, dass man mit einem der 10 führenden weltweit
NANOBIOTIX Announces First Patient Injected with NBTXR3 in Pancreatic Cancer and Safe to Proceed Notifications for Two Additional Trials From U.S. FDA
Regulatory News:
NANOBIOTIX (Paris:NANO) (Euronext: NANO - ISIN: FR0011341205 – the “Company”), a clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today
EOS imaging: First EOSedge™ Installation in Australia
EOS imaging (Euronext, FR0011191766 - EOSI - PEA-PME eligible), a leader in 2D/3D orthopedic medical imaging and software solutions for 3D anatomical modeling and surgical planning, announces the
LivaNova Confirms Receipt of Letter from PrimeStone Capital
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today confirmed receipt of a letter from PrimeStone Capital LLP (PrimeStone) to its Board of Directors and
EOS imaging: First EOSedgeTM Installation in Australia
Regulatory News:
EOS imaging (Paris:EOSI) (Euronext, FR0011191766 - EOSI - PEA-PME eligible), a leader in 2D/3D orthopedic medical imaging and software solutions for 3D anatomical modeling and
Humana, Humana Foundation Commit More Than $1 Million to COVID-19 Relief and Recovery Efforts in Georgia
Together, Humana Inc. (NYSE: HUM) and the company’s philanthropic arm, The Humana Foundation, have committed more than $1 million in COVID-19 relief for communities in Georgia to date.
“The